A review of recent advances in anticancer activity and SAR of pyrazole derivatives

被引:1
作者
Hofny, Heba A. [1 ,2 ]
Mohamed, Mamdouh F. A. [1 ]
Hassan, Heba A. [2 ]
Abdelhafez, El-Shimaa M. N. [2 ]
Abuo-Rahma, Gamal El-Din A. [2 ,3 ]
机构
[1] Sohag Univ, Fac Pharm, Dept Pharmaceut Chem, Sohag 82524, Egypt
[2] Minia Univ, Fac Pharm, Dept Med Chem, Al Minya 61519, Egypt
[3] Deraya Univ, Fac Pharm, Dept Pharmaceut Chem, New Minia, Egypt
关键词
anticancer targets; histone deacetylase inhibitors; hybrids; pyrazole; structure-activity relationship; ANHYDRASE ISOFORMS IX; GROWTH-FACTOR-BETA; JANUS KINASE 2; BIOLOGICAL EVALUATION; HISTONE DEACETYLASE; IN-VITRO; MOLECULAR DOCKING; POTENTIAL ANTICANCER; HYDRAZONE DERIVATIVES; DESIGN;
D O I
10.1002/ardp.202400470
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present review serves to highlight the antitumor worth of pyrazole derivatives. Several active pyrazole-based anticancer compounds proposed by a huge number of scientists worldwide are reported. Regarding the development of novel pyrazole-based anticancer agents at a faster tone, there is a need to correlate the latest information with previously available information to understand the situation of this moiety in anticancer drug discovery studies. Herein, different anticancer pyrazoles are classified according to their mode of action at different anticancer targets. The results provided evidence that pyrazole derivatives have potential applications for the treatment of a variety of tumor types. From the study's findings, the structure-activity relationship (SAR) results demonstrated that all the compounds containing substituted pyrazole represent an important scaffold for anticancer activities. Publications in this area are increasing, and therefore, new therapeutic applications involving members of pyrazole derivatives could be discovered in the near future, as many prospects have not been sufficiently studied so far for other targets. In other words, this review provides an overview of the state of knowledge about the structural characteristics of the most recent anticancer pyrazole derivatives and their SAR with various targets. This will allow medicinal chemists to identify promising structures to guide the design and synthesis of more effective and safer anticancer candidates.
引用
收藏
页数:30
相关论文
共 170 条
[41]  
El-Ossaily Y.A., 2024, Curr. Chem. Lett., V13, P127, DOI [10.5267/j.ccl.2023.8.003, DOI 10.5267/J.CCL.2023.8.003]
[42]   Synthesis of phthalazine-based derivatives as selective anti-breast cancer agents through EGFR-mediated apoptosis: in vitro and in silico studies [J].
Emam, Sara M. M. ;
El Rayes, Samir M. ;
Ali, Ibrahim A. I. ;
Soliman, Hamdy A. A. ;
Nafie, Mohamed S. S. .
BMC CHEMISTRY, 2023, 17 (01)
[43]   New 1,2,3-triazole/1,2,4-triazole hybrids linked to oxime moiety as nitric oxide donor selective COX-2, aromatase, B-RAFV600E and EGFR inhibitors celecoxib analogs: design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis and molecular modeling study [J].
Fadaly, Wael A. A. ;
Nemr, Mohamed T. M. ;
Zidan, Taha H. ;
Mohamed, Fatma E. A. ;
Abdelhakeem, Marwa M. ;
Abu Jayab, Nour N. ;
Omar, Hany A. ;
Abdellatif, Khaled R. A. .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
[44]   New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies [J].
Fadaly, Wael A. A. ;
Elshaier, Yaseen A. M. M. ;
Hassanein, Emad H. M. ;
Abdellatif, Khaled R. A. .
BIOORGANIC CHEMISTRY, 2020, 98
[45]   Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities [J].
Fahmy, Hoda H. ;
Khalifa, Nagy M. ;
Ismail, Magda M. F. ;
El-Sahrawy, Hend M. ;
Nossier, Eman S. .
MOLECULES, 2016, 21 (03)
[46]   Design, synthesis and biological evaluation of new series of benzotriazole-pyrazole clubbed thiazole hybrids as bioactive heterocycles: Antibacterial, antifungal, antioxidant, cytotoxicity study [J].
Gangurde, Keshav B. ;
More, Rahul A. ;
Adole, Vishnu A. ;
Ghotekar, Dattatray S. .
JOURNAL OF MOLECULAR STRUCTURE, 2024, 1299
[47]   A comprehensive review on pyrazoline based heterocyclic hybrids as potent anticancer agents [J].
Haider, Kashif ;
Shafeeque, Mohd ;
Yahya, Shaikh ;
Yar, M. Shahar .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2022, 5
[48]   Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors [J].
Hart, Amy C. ;
Schroeder, Gretchen M. ;
Wan, Honghe ;
Grebinski, James ;
Inghrim, Jennifer ;
Kempson, James ;
Guo, Junqing ;
Pitts, William J. ;
Tokarski, John S. ;
Sack, John S. ;
Khan, Javed A. ;
Lippy, Jonathan ;
Lorenz, Matthew V. ;
You, Dan ;
McDevitt, Theresa ;
Vuppugalla, Ragini ;
Zhang, Yueping ;
Lombardo, Louis J. ;
Trainor, George L. ;
Purandare, Ashok V. .
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (08) :845-849
[49]  
He SP, 2018, J MED CHEM, V61, P7245, DOI [10.1021/acs.jmedchem.8b0064, 10.1021/acs.jmedchem.8b00664]
[50]   Prescribed drugs containing nitrogen heterocycles: an overview [J].
Heravi, Majid M. ;
Zadsirjan, Vahideh .
RSC ADVANCES, 2020, 10 (72) :44247-44311